EMX2OS has shown significant diagnostic and prognostic value in a variety of cancers, such as gastric cancer and renal clear cell carcinoma, where its expression level is significantly correlated with patient grade, stage and cancer status (22, 23). Here, EMX2OS is linked to gastric cancer.